165 related articles for article (PubMed ID: 27779436)
1. Observational Prospective study to esTIMAte the rates of outcomes in patients undergoing PCI with drug-eluting stent implantation who take statins -follow-up (OPTIMA II).
Karpov Y; Logunova N; Tomilova D; Buza V; Khomitskaya Y
Curr Med Res Opin; 2017 Feb; 33(2):253-259. PubMed ID: 27779436
[TBL] [Abstract][Full Text] [Related]
2. Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent.
Ito T; Fujita H; Tani T; Ohte N
Atherosclerosis; 2015 Apr; 239(2):311-7. PubMed ID: 25682029
[TBL] [Abstract][Full Text] [Related]
3. Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
Circ J; 2020 Sep; 84(10):1837-1845. PubMed ID: 32863287
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention.
Seo SM; Choo EH; Koh YS; Park MW; Shin DI; Choi YS; Park HJ; Kim DB; Her SH; Lee JM; Park CS; Kim PJ; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Park YG; Seung KB;
Heart; 2011 Dec; 97(23):1943-50. PubMed ID: 21665885
[TBL] [Abstract][Full Text] [Related]
5. Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry.
Gilis-Siek N; Fijalkowski M; Jaguszewski M; Targonski R; Strozyk A; Cackowska M; Masiewicz E; Skarzynski P; Burakowski S; Chmielecki M; Lewicki L; Dubaniewicz W; Gruchala M; Ciecwierz D; Rynkiewicz A
J Invasive Cardiol; 2013 Nov; 25(11):567-72. PubMed ID: 24184890
[TBL] [Abstract][Full Text] [Related]
6. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
[TBL] [Abstract][Full Text] [Related]
7. Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
Sakamoto T; Ogawa H; Nakao K; Hokimoto S; Tsujita K; Koide S; Yamamoto N; Shimomura H; Matsumura T; Oshima S; Kikuta K; Oka H; Kimura K; Matsui K;
J Cardiol; 2016 Apr; 67(4):371-7. PubMed ID: 26254019
[TBL] [Abstract][Full Text] [Related]
8. Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease.
Niccoli G; Sgueglia GA; Cosentino N; Piro M; Toma A; Cataneo L; Fracassi F; Porto I; Leone AM; Burzotta F; Trani C; Crea F
Eur J Prev Cardiol; 2012 Oct; 19(5):914-26. PubMed ID: 21840968
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy.
Qiu F; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Parvataneni R; Kirtane AJ; Stone GW; Maehara A
JACC Cardiovasc Interv; 2016 Jul; 9(14):1499-507. PubMed ID: 27478119
[TBL] [Abstract][Full Text] [Related]
11. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
13. [Long-Term Statin Adherence in Patients with Stable Angina after Coronary Stenting].
Tomilova DI; Karpov YA; Lopukhova VV
Kardiologiia; 2018 May; (5):65-71. PubMed ID: 29870326
[TBL] [Abstract][Full Text] [Related]
14. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
16. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Guedeney P; Claessen BE; Baber U; Camaj A; Sorrentino S; Aquino M; Blum M; Chandiramani R; Goel R; Elsayed S; Kovacic JC; Sweeny J; Barman N; Moreno P; Dangas GD; Kini A; Sharma S; Mehran R
Am J Cardiol; 2019 Jun; 123(11):1788-1795. PubMed ID: 30955866
[TBL] [Abstract][Full Text] [Related]
18. Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.
Kristensen SL; Galløe AM; Thuesen L; Kelbæk H; Thayssen P; Havndrup O; Hansen PR; Bligaard N; Saunamäki K; Junker A; Aarøe J; Abildgaard U; Jeppesen JL
PLoS One; 2014; 9(11):e113399. PubMed ID: 25409336
[TBL] [Abstract][Full Text] [Related]
19. Visit-to-visit variability of systolic blood pressure predicts all-cause mortality in patients received percutaneous coronary intervention with drug-eluting stents.
Seo SM; Chung WB; Choi IJ; Koh YS; Ihm SH; Kim PJ; Chung WS; Seung KB
Heart Vessels; 2018 May; 33(5):489-497. PubMed ID: 29151154
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
